Stock Movers

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers:

- Nike (NKE) shares slide as much as 14%, to the lowest level since Feb. 2015, after the sportswear company forecast a revenue drop of as much as 4% for the fourth quarter, and warned sales declines could persist for the rest of this calendar year.

- Intel (INTC) shares are up 9.8% on Wednesday, after the chipmaker agreed to pay $14.2 billion to buy back half of a plant in Ireland. D.A. Davidson wrote that the move bodes well for the company’s turnaround story.

- Tesla (TSLA) likely delivered about 372,160 vehicles during the last three months, up about 11% from a year ago, but still among the lowest recent quarterly totals for the company. Slower sales are likely the new normal for Tesla as it pivots its focus to AI, autonomy and robotics amid weakening global EV demand and a US market that now lacks a federal tax incentive for plug-in cars. Shares rose as a result.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:

- Intel (INTC) shares jump. Intel Corp. agreed to pay $14.2 billion to buy back half of a plant in Ireland that it had previously sold to Apollo Global Management. The transaction will be financed with cash on hand and the issuance of about $6.5 billion in new debt, according to Intel.

- Boeing (BA) The Pentagon announced a partnership with Boeing and Lockheed Martin to triple the production capacity of seekers for the Patriot Advanced Capability-3 Missile Segment Enhancement, according to a statement.

- Nike (NKE) shares drop after the company announced a disappointing forecast, causing the company's shares to fall, and Chief Executive Officer Elliott Hill expressed frustration to staff.

See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers:

- RH shares plunge after the home furnishing company forecast revenue for the first quarter that missed the average analyst estimate. 

- Beyond Meat (BYND) forecast net revenue for the first quarter; the guidance missed the average analyst estimate.

- Tilray Brands (TLRY) reaffirmed its adjusted Ebitda guidance for the full year; the guidance beat the average analyst estimate.

See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Nike (NKE) shares tumbled after the retailer gave a surprisingly gloomy outlook for the year ahead, complicating Chief Executive Officer Elliott Hill’s efforts to turn around the business. Revenue is expected to decline 2% to 4% in the current quarter and will be down in the low single-digits for the rest of the calendar year, management told investors on an earnings call Tuesday evening. Analysts surveyed by Bloomberg had been looking for 2% sales growth this quarter and bigger gains as the year progressed.
- RH shares plunge after the upscale furnishing company forecast revenue for the first quarter that missed the average analyst estimate. Analysts say the forecast is pressured by execution and supply chain disruptions.
- Walt Disney (DIS) shares rises as Raymond James upgrades to outperform from market perform, citing an attractive entry point for the stock.

See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Rolls-Royce shares jump as much as 10%, the biggest gain in eight months.
-  Lufthansa is readying plans to ground planes in case demand drops because of the war in the Middle East. Europe’s biggest aviation group has assigned teams to develop crisis responses that differ in severity, Chief Executive Officer Carsten Spohr told employees Tuesday, according to a spokesman for Lufthansa.
- Berkeley shares plunged the most in almost 10 years after the UK housebuilder signaled smaller-than-anticipated earnings in the medium term, citing reduced potential for interest rate cuts on account of the Iran War.

See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Shell shares dip as much 2.4% amidst uncertainty in energy markets tied to the Middle East conflict.
-  Lufthansa is readying plans to ground planes in case demand drops because of the war in the Middle East. Europe’s biggest aviation group has assigned teams to develop crisis responses that differ in severity, Chief Executive Officer Carsten Spohr told employees Tuesday, according to a spokesman for Lufthansa.
- Berkeley shares plunged the most in almost 10 years after the UK housebuilder signaled smaller-than-anticipated earnings in the medium term, citing reduced potential for interest rate cuts on account of the Iran War.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:

- Nike (NKE) shares slipped despite reporting better-than-expected sales on concerns that the war in Iran could exacerbate weakness in the region that includes Europe and the Middle East and disrupt the sportswear company’s turnaround. Sales were $11.3 billion in the company’s fiscal third quarter, surpassing the average of estimates compiled by Bloomberg but flat from a year earlier. While performance in China improved, the Converse brand remained a problem area and the EMEA region, which also includes Africa, missed estimates.

- Airlines climb as much as: United +8.6%, Delta +6.7%, American +6.1%. The S&P Supercomposite Airlines Industry Index jumps as much as 6.6%, the most since Feb. 6. Jet fuel prices have soared during the war, prompting warnings from across Wall Street about the financial impact on carriers and pushing the airlines index into a bear market

- Biogen has agreed to acquire Apellis Pharmaceuticals Inc. for $5.6 billion, expanding its treatments in immunology and rare diseases in one of the company’s largest-ever acquisitions.The Cambridge, Massachusetts-based biotech company will pay $41 a share for Apellis, more than double its closing price on Monday, Biogen said in a statement, confirming a Bloomberg News report. Apellis’ (APLS) stock had declined 32% so far this year through Monday’s close. Apellis shares soared 135% to $40.23 on Tuesday in New York, their largest jump ever. Biogen shares closed down 2.3%.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:

Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greifeld, Carol Massar and Tim Stenovec.

- Marvell Technology (MRVL) shares soared in trading on Tuesday on news that Nvidia will take a $2 billion stake in it. Nvidia, which has made several billion-dollar investments in firms across the artificial intelligence supply chain in recent years, and Marvell also agreed to collaborate on the development of silicon photonics, which use light instead of traditional copper wiring to move data faster and more efficiently. And the companies will work together on ways to better leverage telecommunications networks for AI computing, according to a statement issued Tuesday.

- Delta Airlines (DAL) will use Amazon.com Inc.’s satellites to deliver in-flight Wi-Fi service, a big win for the e-commerce giant’s space business as it vies with Elon Musk’s Starlink for aviation customers. Delta agreed to install the Amazon Leo internet service on 500 aircraft starting in 2028, enabling faster and more reliable internet to support streaming video and messaging, according to a Tuesday announcement from the airline. Shares of Delta rallied.

- McCormick (MKC) shares slipped in trading on Tuesday as the spice company agreed to combine with Unilever’s Foods business in a deal valuing Unilever Foods at about $44.8 billion and at enterprise value for McCormick of about $21.0 billion.

See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers:
- Constellation Energy (CEG) shares fell as much as 9.3% after it gave an full-year earnings per share guidance that missed the average analyst estimate at the midpoint, and failed to advance details on data-center deals.

- Marvell Technology (MRVL) shares jumped as much as 11% in trading on Tuesday on news that Nvidia (NVDA) is taking a $2 billion stake in it. Nvidia, which has made several billion-dollar investments in firms across the artificial intelligence supply chain in recent years, and Marvell also agreed to collaborate on the development of silicon photonics, which use light instead of traditional copper wiring to move data faster and more efficiently. And the companies will work together on ways to better leverage telecommunications networks for AI computing, according to a statement issued Tuesday.

- Unilever (ULVR) shares fall as much as 7.3% in London to the lowest level since April 2024 after the Anglo-Dutch company confirmed a $44.8 billion deal to combine its food business with spice maker McCormick. Analysts at RBC Capital Markets said they are unimpressed by the deal. McCormick shares fell as much as 10% to the lowest since November 2017.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:

- Constellation Energy (CEG) shares fall after it gave an full-year earnings per share guidance that missed the average analyst estimate at the midpoint.

- McCormick (MKC) shares decline. Unilever Plc agreed to combine its food business with McCormick & Co. in a $44.8 billion deal that will create a global seasonings, sauces and condiments company. Under the agreement, McCormick will pay Unilever $15.7 billion and the equivalent of $29.1 billion McCormick shares for most of Unilever’s food business, leaving Unilever and its shareholders with 65% of the combined entity.

- Apellis Pharmaceuticals (APLS) shares gain after Biogen agreed to acquire Apellis for $5.6 billion, expanding its treatments in immunology and rare diseases. The acquisition will give Biogen two approved drugs, Syfovre and Empaveli, which treat immune disorders and rare diseases, including a leading cause of blindness and rare kidney diseases.

See omnystudio.com/listener for privacy information.